APA (7th ed.) Citation

Ikenaga, H., Kozuka, R., Inoue, K., Matsubara, T., Odagiri, N., Yoshida, K., . . . Uchida-Kobayashi, S. (2026). 12-Hydroxyheptadecatrienoic Acid Predicts Hepatocellular Carcinoma Development During Nucleos(t)ide Analogue Therapy. Cancers, 18(4), 542. https://doi.org/10.3390/cancers18040542

Chicago Style (17th ed.) Citation

Ikenaga, Hiroko, et al. "12-Hydroxyheptadecatrienoic Acid Predicts Hepatocellular Carcinoma Development During Nucleos(t)ide Analogue Therapy." Cancers 18, no. 4 (2026): 542. https://doi.org/10.3390/cancers18040542.

MLA (9th ed.) Citation

Ikenaga, Hiroko, et al. "12-Hydroxyheptadecatrienoic Acid Predicts Hepatocellular Carcinoma Development During Nucleos(t)ide Analogue Therapy." Cancers, vol. 18, no. 4, 2026, p. 542, https://doi.org/10.3390/cancers18040542.